[The role of high-dosage neuroleptic therapy and electroshock in the treatment of the acute phase of schizophrenia].
The authors studied the effectiveness of neuroleptic high-dosage therapy in comparison to the electroshock treatment in the acute phase of systematic and unsystematic schizophrenia in a total of 75 patients. The results obtained show that the neuroleptic high-dosage therapy exceeds the effectiveness of the electroshock treatment mainly in the group of unsystematic schizophrenia.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004565:Electroconvulsive Therapy; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000628:therapy*; D014282:Trihexyphenidyl / Q000627:therapeutic use
D014150:Antipsychotic Agents; D014282:Trihexyphenidyl; D006220:Haloperidol
Zur Rolle der neureleptischen Hochdosis-Therapie und des Elektroschocks bei der Behandlung der akuten Phase von Schizophrenien.